This podcast from EZ Endo Prep delivers concise, high yield endocrinology content to help you study smarter and practice with confidence. Each episode breaks down complex topics into manageable pieces, making it ideal for endocrinology fellows and practicing endocrinologists. Whether you're preparing for boards or staying sharp in clinic, Dr. Sumbul Beg, MD brings exam ready pearls and real world relevance straight to your ears.

Endo in a Bite
Claim This Podcastby Sumbul Beg, MD
Podcast Overview
This podcast from EZ Endo Prep delivers concise, high yield endocrinology content to help you study smarter and practice with confidence. Each episode breaks down complex topics into manageable pieces, making it ideal for endocrinology fellows and practicing endocrinologists. Whether you're preparing for boards or staying sharp in clinic, Dr. Sumbul Beg, MD brings exam ready pearls and real world relevance straight to your ears.
Language
🇺🇲
Publishing Since
7/9/2025
2 verified contact emails on file for Endo in a Bite
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes

August 10, 2026
The 2026 Consensus Statement on the Algorithm for Management of Adults with Type 2 Diabetes: Insulin Management (Part 1)
<p>In this episode, we review the 2026 Consensus Statement algorithm for insulin management in adults with type 2 diabetes. Topics include individualized glycemic targets, the role of continuous glucose monitoring (CGM), key CGM metrics and glycemic variability, recognition of severe hyperglycemia, when to initiate insulin, the role of GLP-1 based therapy before insulin in clinically stable patients, and practical strategies for optimizing insulin therapy while minimizing hypoglycemia.</p>

August 3, 2026
The 2026 Consensus Statement on the Algorithm for Management of Adults with Type 2 Diabetes: Glucose Centric Management (Episode 10)
<p>In this episode, we review the 2026 Consensus Statement algorithm for glucose centric management in adults with type 2 diabetes. Topics include identifying patients appropriate for a glucose centric approach, metformin as foundational therapy, individualized medication selection based on weight, hypoglycemia risk, cost and access, early combination therapy, management of severe hyperglycemia, appropriate insulin initiation, avoiding inappropriate incretin combinations, and practical strategies for treatment intensification and reducing therapeutic inertia.</p>

July 27, 2026
The 2026 Consensus Statement on the Algorithm for Management of Adults with Type 2 Diabetes: Metabolic Dysfunction Associated Steatotic Liver Disease (Episode 9)
<p>In this episode, we review the 2026 Consensus Statement algorithm for metabolic dysfunction associated steatotic liver disease (MASLD) management in adults with type 2 diabetes. Topics include the epidemiology and diagnosis of MASLD, progression to metabolic dysfunction associated steatohepatitis (MASH), lifestyle interventions and weight loss goals, the role of resmetirom, GLP-1 receptor agonists, tirzepatide, pioglitazone, and SGLT2 inhibitors, and practical evidence based strategies to improve liver health and reduce cardiovascular, renal, and hepatic complications.</p><p><br></p>
59 total episodes available
Similar Podcasts
Discover related shows you might enjoy

Diabetes Core Update
American Diabetes Association

Endocrine Feedback Loop
Endocrine Society

AACE Podcasts
AACE

Endocrine News Podcast
Endocrine Society

The Curbsiders Internal Medicine Podcast
The Curbsiders Internal Medicine Podcast

JAMA Clinical Reviews
JAMA Network

Docs Who Lift
Docs Who Lift

Annals On Call Podcast
American College of Physicians

NEJM This Week
NEJM Group

Freakonomics Radio
Freakonomics Radio + Stitcher

The Daily
The New York Times

Pod Save America
Pod Save America

Wannabe Clutter Free | Declutter, Organize, Calm the Chaos
Deanna Yates | Professional Organizer, Decluttering Coach, Wannabe Minimalist

Endocrinology Review
Saif Borgan M.D.

The Thyroid Stimulating Podcast
Medscape
Deep-dive analytics for Endo in a Bite
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Endo in a Bite?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
No, this podcast does not typically feature guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.
